GSK buys full rights to make COVID, influenza vaccines from CureVac
Wednesday, July 3rd 2024, 6:25:52 am
article
The deal is the result of restructuring a collaboration, which began in 2020 to develop mRNA-based vaccines for infectious diseases, into a new licensing agreement, GSK added. As a result of the collaboration, the two companies have vaccine candidates for seasonal influenza and COVID-19 in phase II clinical development and avian influenza in phase I clinical development.
Breaking
From the most overpriced pizza chains to sugar-loaded coffee drinks and America's tipping backlash, here's what's stirring up debate....
Kacey Musgraves and Miranda Lambert resolve their rumored feud with a collaboration on Musgraves' upcoming album "Middle of Nowhere," set for release in May....
Virginia mother Cheryl Minter calls on Fairfax County Commonwealth's Attorney Steve Descano to "do your job" after her daughter was allegedly stabbed to death at a bus stop....
